Jul 25, 2017 @ 07:58
The Ontario Government is asking patients, health care providers and the pharmaceutical and medical devices industries about regulations and guidelines that govern the disclosure of payments from the private sector to health care professionals.
One concern driving this is the desire for the public to have private drug companies disclose payments made by drug companies to health care providers.
The Ministry of Heath explains “The consultations are part of a broader effort to open up the health care system and make it more accountable and transparent, delivering on Ontario’s commitment to Open Government and to becoming the most open and transparent government in Canada.”
On June 20, 2017, 10 brand pharmaceutical companies, including GlaxoSmithKline (GSK), released aggregate Canadian data that showed they paid nearly $50 million to Canadian health-care professionals and organizations last year.